Skip to content

Evera™ XT DR DDBB1D4 (UDI 00763000059699)Recalls & reported problems

Medtronic, Inc. · ICD-DR DDBB1D4 EVERA XT US IS1/DF4 · Class 3 · Implant

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
7
Deaths reported
0
Injuries reported
5
Recalls naming it
1

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00763000059699), received between Mar 4, 2019 and Dec 19, 2025 — classified as 5 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Device Sensing Problem” (5 reports).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. May 10, 2023Open, Classified

    There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) manufactured with a specific (glassed) feedthrough, including currently available ICDs and CRT-Ds.

    Z-1705-2023 · Root cause: Under Investigation by firm · FDA record ↗

Most reported problems

Device problems

  • Device Sensing Problem5
  • Inappropriate/Inadequate Shock/Stimulation4
  • Adverse Event Without Identified Device or Use Problem1
  • Electrical /Electronic Property Problem1
  • Pacing Problem1

Patient problems

  • Shock from Patient Lead(s)4
  • No Clinical Signs, Symptoms or Conditions1
  • No Patient Involvement1
  • Sepsis1
  • Unspecified Infection1

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 19, 2025Pacing Problem; Device Sensing Problem; Pacing Problem; Device Sensing Problem

    IT WAS REPORTED THAT THE PATIENT RECEIVED POSSIBLE INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) FROM THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) FOR ATRIAL TACHYCARDIA/ATRIAL FIBRILLATION (AT/AF) WITH RAPID VENTRICULAR RESPONSE  THAT WAS DETECTED AS VENTRICULAR TACHYCARDIA (VT). THE ICD REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23850946 ↗
  • InjurySep 18, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM WAS EXPLANTED DUE TO INFECTION. THE SOURCE OF THE INFECTION WAS LISTED AS SEPTICEMIA. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: Sepsis; Unspecified Infection

    MAUDE report 20245631 ↗
  • InjuryApr 29, 2024Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem

    IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DETECTED VENTRICULAR FIBRILLATION (VF) AND DELIVERED A SHOCK. IT WAS SUSPECTED THAT THE RHYTHM WAS ATRIAL FIBRILLATION (AF) WITH RAPID VENTRICULAR RESPONSE (RVR), THEREFORE THE SHOCK WAS INAPPROPRIATE. ADDITIONALLY, IT WAS NOTED THAT THERE WAS UNDERSENSING ON THE RIGHT VENTRICULAR (RV) LEAD PRIOR TO DETECTION THAT DID NOT APPEAR TO DELAY DETECTION. THE ICD AND LEAD REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 19201755 ↗
  • InjurySep 9, 2022Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem

    IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DETECTED VENTRICULAR TACHYCARDIA (VT) AND DELIVERED A SHOCK, AND VENTRICULAR FIBRILLATION (VF) AND DELIVERED A SHOCK. IT WAS SUSPECTED THAT THE RHYTHMS WERE ACTUALLY ATRIAL FIBRILLATION (AF) WITH RAPID VENTRICULAR RESPONSE (RVR) AND THEREFORE THE SHOCKS ARE INAPPROPRIATE. IT WAS ALSO NOTED THAT THERE WAS OVERSENSING ON THE RIGHT VENTRICULAR (RV) LEAD. THE DEVICE WAS EXPLANTED AND REPLACED, AND THE LEAD REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 15393832 ↗
  • InjuryMay 22, 2019Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem

    IT WAS REPORTED THAT THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) POSSIBLY A SHOCK FOR AT/AF (ATRIAL TACHYCARDIA/ ATRIAL FIBRILLATION) WITH RVR (RAPID VENTRICULAR RESPONSE). THE ICD REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 8632186 ↗
  • InjuryApr 22, 2019Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem; Inappropriate/Inadequate Shock/Stimulation; Device Sensing Problem

    IT WAS FURTHER REPORTED THROUGH FOLLOW-UP OBTAINED THAT THE PHYSICIAN DID NOT FEEL THE PATIENT RECEIVED INAPPROPRIATE THERAPY.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 8536818 ↗
  • MalfunctionMar 4, 2019Electrical /Electronic Property Problem; Electrical /Electronic Property Problem

    IT WAS REPORTED THAT THE DEVICES WERE INTERROGATED AND THE BATTERY VOLTAGE WAS BELOW THE LEVEL INDICATED FOR IMPLANT. THE BATTERY VOLTAGE WAS STILL BELOW THE LEVEL INDICATED FOR IMPLANT AFTER THE DEVICES WERE LEFT AT ROOM TEMPERATURE. THE DEVICES WERE NOT USED. THERE WAS NO PATIENT INVOLVEMENT.

    Patient problems: No Patient Involvement

    MAUDE report 8387987 ↗

Other Implantable cardioverter defibrillator (non-CRT) devices

All Implantable cardioverter defibrillator (non-CRT) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.